CONCORD BIOTECH
Back to Cashflow Statement
|
CONCORD BIOTECH Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹12 Cr | ₹2.83 Cr | ₹-4.48 Cr | ₹2.74 Cr | ₹-1.35 Cr |
What is the latest Net Cash Inflow / Outflow ratio of CONCORD BIOTECH ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹12 Cr |
Mar2023 | ₹2.83 Cr |
Mar2022 | ₹-4.48 Cr |
Mar2021 | ₹2.74 Cr |
Mar2020 | ₹-1.35 Cr |
How is Net Cash Inflow / Outflow of CONCORD BIOTECH Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹12 Cr | 311.12 | |
Mar2023 | ₹2.83 Cr | Positive | |
Mar2022 | ₹-4.48 Cr | Negative | |
Mar2021 | ₹2.74 Cr | Positive | |
Mar2020 | ₹-1.35 Cr | - |
Compare Net Cash Inflow / Outflow of peers of CONCORD BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CONCORD BIOTECH | ₹19,429.5 Cr | 1.6% | -3.5% | 59.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹445,964.0 Cr | -2.3% | -2.9% | 69.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,653.0 Cr | 1.6% | 8.7% | 74% | Stock Analytics | |
CIPLA | ₹125,920.0 Cr | 3.7% | -5.9% | 29.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,011.0 Cr | -4.1% | -6.6% | 18.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,026.0 Cr | -0.3% | -6.1% | 74.6% | Stock Analytics |
CONCORD BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CONCORD BIOTECH | 1.6% |
-3.5% |
59.9% |
SENSEX | 0.4% |
-5.4% |
24.4% |
You may also like the below Video Courses